Cybin (HELP) Depreciation and Depletion (2020 - 2023)
Cybin (HELP) posted quarterly Depreciation and Depletion of -$56037.0 for Q1 2023, down 1051.88% year-on-year from $5887.0 in Q1 2022, and down 1352.5% on a QoQ basis from $4474.0 in Q2 2022.
Cybin (HELP) Depreciation and Depletion (2020 - 2023) Analysis & Trends
Cybin (HELP) has reported Depreciation and Depletion for 4 consecutive years, with -$56037.0 the latest figure, recorded in Q1 2023.
- Quarterly Depreciation and Depletion fell 1051.88% year-over-year to -$56037.0 in Q1 2023, while the trailing twelve-month figure through Feb 2023 was -$10769.2 (down 110.25% YoY) and the FY2023 annual result came in at $36915.1, up 125.73% from the prior year.
- Depreciation and Depletion fell to -$56037.0 in Q1 2023 per HELP's latest filing, from $4474.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for HELP reached as high as $34906.8 in Q4 2021 and fell as low as -$56037.0 in Q1 2023.
- A 4-year average of $9068.8 and a median of $9971.7 in 2020 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2021 — Depreciation and Depletion soared 250.06% — and 2023, when it sank 1051.88%.
- Year by year, Depreciation and Depletion stood at $9971.7 in 2020, then surged by 250.06% to $34906.8 in 2021, then slumped by 87.18% to $4474.0 in 2022, then sank by 1352.5% to -$56037.0 in 2023.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered -$56037.0, $4474.0, and $5887.0 for Q1 2023, Q2 2022, and Q1 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2023 | -56,036.99 |
| Feb 28, 2023 | -56,036.99 |
| May 31, 2022 | 4,474.02 |
| May 31, 2022 | 4,474.02 |
| Feb 28, 2022 | 5,886.99 |
| Feb 28, 2022 | 5,886.99 |
| Dec 31, 2021 | 34,906.79 |
| Dec 31, 2021 | 34,906.79 |
| Sep 30, 2021 | 33,365.19 |
| Sep 30, 2021 | 33,365.19 |
| Jun 30, 2021 | 30,914.03 |
| Jun 30, 2021 | 30,914.03 |
| Dec 31, 2020 | 9,971.71 |
| Dec 31, 2020 | 9,971.71 |